AI and rare diseases
The challenges of AI for rare diseases: structuring high-impact projects
Clinical, organizational, regulatory and economic aspects of rare disease management
by pharmaceutical companies represent a real challenge for them.
Diagnostic error, fragmented healthcare data, a multiplicity of players and delays in access to innovations are all issues that can be addressed by artificial intelligence in healthcare.
To speed up patient identification, improve patient care and build precision medicine, AI is an accessible opportunity.
Provided you structure the right projects, with the right partners, at the right time.
Digital Pharma Lab expertise: transforming a complex problem into a structured, concrete project for your laboratory
We operate as a consulting firm specializing in healthcare innovation
to support manufacturers at every stage in the implementation of AI & rare diseases projects.
From patient identification to structuring smoother patient pathways, we position our customers as pioneers in these fields.
Our mission begins with strategic thinking and continues through to clinical validation. Our approach aims to secure choices, unite stakeholders and maximize operational impact.
Accelerating innovation in AI and rare diseases
AIs have a role to play in the diagnosis of rare diseases, by accelerating the recognition of signs and symptoms in particular. We propose the co-deployment of clinically useful and regulatory-compliant algorithms.
We strengthen your image as a leader by leveraging healthcare data
Data and the sharing of it are the sore point of the healthcare of the future. Yet it is the sine qua non for the deployment of AI in healthcare. We work to enhance the use of data within a secure and controlled framework.
We create sustainable coalitions like NextGen Coalition and IDEO
Join us in the first healthcare coalition with the right partners (startups, university hospitals, institutions). Since 2020, we have been at the origin of coalitions between players who together develop high-impact innovation projects, particularly involving artificial intelligence.
Our methodology
Our teams master the codes, processes and decision-making cycles of the pharmaceutical industry. Our 360° methodology secures your investments, and evolves within an ecosystem that can be mobilized immediately, for example by making consultants available on a contract basis.
1. Diagnosis and definition of use cases
This is an essential first step in diagnosing and identifying the most valuable use cases (e.g., reducing diagnostic wandering).
2. Setting up access to healthcare data and partnerships
We structure access to healthcare data by mobilizing existing databases (BNDMR, HDH, Ouest Data Hub...). Then we federate technological and clinical partners around your project.
3. Co-piloting, deployment and valorization
Together with your teams and business experts, we steer the development and validation of AI. Finally, we orchestrate the visibility and promotion of the project, both internally and externally (scientific, institutional, corporate).
Our strength: an active network of key players in the field of digital technology and rare diseases
All the players in digital health and AI applied to rare diseases are covered by our expertise.
- Startups AI santé & healthtech
- University hospitals, referring clinicians and rare disease expert centers
- Public institutions & funders (France 2030, BPI, EIT Health, ARIIS)
- Fondation Maladies Rares, Alliance Maladies Rares
- Experts in regulatory affairs, healthcare data and applied AI
They trust us
Some customer references
With over 150 innovation projects supported
we support more than 40 healthcare players, from project design to deployment, in their innovation strategy and digital transformation.
Our mission is to create experiences where strategy, innovation and collaboration meet.
INTERNATIONAL DEPLOYMENT DTX
We support the collaboration between Sanofi's German subsidiary and startup ProCarement, which aims to improve the care of heart failure patients through a digital approach to care.
FAQ AI and rare diseases
Answers to frequently asked questions
Ready to accelerate your innovation in healthcare?
Contact us to discuss your projects and explore how we can support you.
"*" indicates required fields